Olinciguat

CAS No. 1628732-62-6

Olinciguat( IW-1701 )

Catalog No. M23726 CAS No. 1628732-62-6

Olinciguat is an oral guanylate cyclase (sGC) stimulator. It also has concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole-cell assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 502 In Stock
5MG 454 In Stock
10MG 655 In Stock
25MG 1026 In Stock
50MG 1376 In Stock
100MG 1823 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Olinciguat
  • Note
    Research use only, not for human use.
  • Brief Description
    Olinciguat is an oral guanylate cyclase (sGC) stimulator. It also has concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole-cell assay.
  • Description
    Olinciguat is an oral guanylate cyclase (sGC) stimulator. It also has concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole-cell assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    IW-1701
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Guanylate Cyclase
  • Recptor
    Guanylate Cyclase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1628732-62-6
  • Formula Weight
    509.39
  • Molecular Formula
    C21H16F5N7O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (245.39 mM; Need ultrasonic)
  • SMILES
    NC([C@](CNc(nc(-c1nn(Cc(cccc2)c2F)c(-c2nocc2)c1)nc1)c1F)(C(F)(F)F)O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Buys ES, et al. Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential. Nitric Oxide. 2018 Aug 1;78:72-80.
molnova catalog
related products
  • BAY 41-2272

    BAY 41-2272 is a potent, NO-independent, orally available soluble guanylate cyclase (sGC) stimulator with IC50 of 0.3 uM.

  • Indusatumab

    Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody utilized for synthesizing antibody-drug conjugates.

  • LY83583

    LY83583 is a soluble guanylate cyclase competitive inhibitor with IC50 of 2 μM.